Purpose: To evaluate the 12 months functional outcome and morphological changes according stages after 3 monthly intravitreal ranibizumab injections for the treatment of retinal angiomatous proliferation (RAP) in Korea. Methods: A retrospective chart review of 40 patients (41 eyes) with RAP was conducted. Patients received three initial monthly intravitreal injections (0.5 mg) of ranibizumab and monitored monthly for 12 months....

Read More